Edesa Biotech
EDSA
9 hedge funds and large institutions have $42K invested in Edesa Biotech in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
2.27% less ownership
Funds ownership: 2.6% → 0.34% (-2.3%)
25% less funds holding
Funds holding: 12 → 9 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
98% less capital inflows, than outflows
Capital inflows: $6.41K | Capital outflows: $381K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Anson Funds Management
Dallas,
Texas
|
-$300K |
| 2 |
Virtu KCG Holdings
New York
|
-$49K |
| 3 |
Chemical Bank
Detroit,
Michigan
|
-$24K |
| 4 |
Advisor Group
Phoenix,
Arizona
|
-$4.52K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$1.88K |
EDSA Hedge Fund Activity: Q2 2017 in Review
9 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2017, worth a combined $42K — down 90% from $430K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EDSA and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $6.41K. The largest seller was Anson Funds Management, exiting entirely with an estimated $300K sold.
- 9 institutional investors held Edesa Biotech (EDSA) as of Q2 2017, down from 12 in Q1 2017.
- Funds reported $42K of Edesa Biotech stock for Q2 2017, down 90% quarter-over-quarter.
- 1 fund opened new Edesa Biotech positions in Q2 2017 and 4 closed out, a net change of -3 holders.
- The largest Edesa Biotech buyer in Q2 2017 was UBS Group, an estimated $6.41K added.
- The largest Edesa Biotech seller in Q2 2017 was Anson Funds Management, an estimated $300K sold.
Based on aggregated 13F filings for Q2 2017.